Modus Therapeutics Holding AB (MODTX) - Total Liabilities

Latest as of December 2025: Skr3.62 Million SEK ≈ $389.03K USD

Based on the latest financial reports, Modus Therapeutics Holding AB (MODTX) has total liabilities worth Skr3.62 Million SEK (≈ $389.03K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Modus Therapeutics Holding AB generate cash to assess how effectively this company generates cash.

Modus Therapeutics Holding AB - Total Liabilities Trend (2018–2025)

This chart illustrates how Modus Therapeutics Holding AB's total liabilities have evolved over time, based on quarterly financial data. See MODTX total equity for net asset value and shareholders' equity analysis.

Modus Therapeutics Holding AB Competitors by Total Liabilities

The table below lists competitors of Modus Therapeutics Holding AB ranked by their total liabilities.

Company	Country	Total Liabilities
First Venture Sweden AB Series B ST:FIRST-B	Sweden	Skr851.00K
BTU Metals Corp V:BTU	Canada	CA$20.11K
Tingo Group Inc. NASDAQ:TIO	USA	$1.33 Billion
Cheetah Net Supply Chain Service Inc. Class A Common Stock NASDAQ:CTNT	USA	$2.66 Million
Pelangi Indah Canindo Tbk JK:PICO	Indonesia	Rp446.12 Billion
Ecofibre Ltd AU:EOF	Australia	AU$32.89 Million
Wool Industry Tria Alfa S.A. AT:AAAK	Greece	€2.68 Million
Sentage Holdings Inc NASDAQ:SNTG	USA	$1.72 Million

Liability Composition Analysis (2018–2025)

This chart breaks down Modus Therapeutics Holding AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Modus Therapeutics Holding AB (MODTX) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.51	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.40	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.28	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Modus Therapeutics Holding AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Modus Therapeutics Holding AB (2018–2025)

The table below shows the annual total liabilities of Modus Therapeutics Holding AB from 2018 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr3.62 Million ≈ $389.03K	+31.60%
2024-12-31	Skr2.75 Million ≈ $295.62K	+16.45%
2023-12-31	Skr2.36 Million ≈ $253.87K	-82.97%
2022-12-31	Skr13.86 Million ≈ $1.49 Million	+153.96%
2021-12-31	Skr5.46 Million ≈ $587.15K	+1000.00%
2020-12-31	Skr496.00K ≈ $53.38K	-89.53%
2019-12-31	Skr4.74 Million ≈ $509.78K	-79.45%
2018-12-31	Skr23.05 Million ≈ $2.48 Million	--

About Modus Therapeutics Holding AB

ST:MODTX Sweden Biotechnology

Market Cap

$5.37 Million

Skr49.87 Million SEK

Market Cap Rank

#28214 Global

#634 in Sweden

Share Price

Skr0.41

Change (1 day)

-2.38%

52-Week Range

Skr0.27 - Skr3.83

All Time High

Skr6.80